Subject Matter Expertise

HOPA takes pride in our members and their valuable contributions to the field of hematology/oncology pharmacy. See some of our member-experts in action below.

lavender background with Members in the News overtop

Expert on Women Pharmacist Day: Mentorship in Oncology Pharmacy Has an Impact

Leanne Kennedy

HOPA President LeAnne Kennedy discusses the importance of mentorship in oncology pharmacy as well as the value of HOPA’s mentorship initiatives.

Pharmacy Times spoke to LeAnne as part of their celebration of Women Pharmacist Day.

Among other takeaways, in the interview LeAnne says, "One of the things that I love to do is to train other people. To see that light, when they get it—when you're explaining a clinical practice subject, and that lightbulb goes off—I think that's so exciting, then to see that as they get involved within HOPA."

Experts: The Hematology-Oncology Pharmacist Great Migration Is Caused by Issues Outside of Burnout That Could Be Quickly Addressed

Zahra Mahmoudjafari, PharmD, BCOP, DPLA; Alison Gulbis, PharmD, BCOP; and Kamakshi Rao, PharmD, BCOP, FASHP, discuss the underlying causes of the hematology-oncology pharmacist great migration from the field.

National Survey on the Effect of Oncology Drug Shortages in Clinical Practice: A Hematology Oncology Pharmacy Association Survey

Ali McBride , PharmD1,2; Sarah Hudson-DiSalle, PharmD3; Jeff Pilz , PharmD3; Mark Hamm, PharmD4; Brooke Boring, MPH5; Larry W. Buie, PharmD6; and David L. DeRemer , PharmD7,8

The purpose of this survey was to characterize the impact of oncology drug shortages across the United States, including the experiences of health care organizations, resource implications, and the impact on patient safety, patient care, and clinical trials.

Spacer Image

HOPA Provides Plan to Address Oncology Drug Shortages

Experts discuss insight from a recently published oncology drug shortages research project and HOPA’s plan to address related issues based on the project’s findings.

Pharmacy Times interviewed Sarah Hudson-Disalle, PharmD, RPh, pharmacy manager in the Department of Pharmacy at the Ohio State Wexner Medical Center and chair of the Public Policy Committee at the Hematology/Oncology Pharmacy Association (HOPA), and Jeffrey Pilz, PharmD, MPA, MS, BCPS, assistant director of pharmacy – medication safety and drug policy in the Department of Pharmacy at the Ohio State Wexner Medical Center and vice chair of the Public Policy Committee at the HOPA, on HOPA’s oncology drug shortages research project.